Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
about
Functional implications of the localization and activity of acid-sensitive channels in rat peripheral nervous systemNeurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxinDifferent Contribution of Redox-Sensitive Transient Receptor Potential Channels to Acetaminophen-Induced Death of Human Hepatoma Cell Line.TRPV1: A Potential Drug Target for Treating Various Diseases.Activation of vanilloid receptor 1 by resiniferatoxin mobilizes calcium from inositol 1,4,5-trisphosphate-sensitive stores.Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugsActivation of the TRPV1 cation channel contributes to stress-induced astrocyte migrationLipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptorHydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airwaysPotentiation of TRPV3 channel function by unsaturated fatty acids.Molecular cloning and functional characterization of Xenopus tropicalis frog transient receptor potential vanilloid 1 reveal its functional evolution for heat, acid, and capsaicin sensitivities in terrestrial vertebrates.N-glycosylation determines ionic permeability and desensitization of the TRPV1 capsaicin receptor.TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation.Biological activity of plant extracts: novel analgesic drugs.A new electro-optical approach for conductance measurement: an assay for the study of drugs acting on ligand-gated ion channels.Licking for taste solutions by potassium-deprived rats: specificity and mechanisms.Lack of potentiating effect of increasing temperature on responses to chemical activators in vagal sensory neurons isolated from TRPV1-null mice.The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvantTransient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease?Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats.The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not.Acid-evoked Ca2+ signalling in rat sensory neurones: effects of anoxia and aglycaemiaVanilloid and melastatin transient receptor potential channels in vascular smooth muscleMoving towards supraspinal TRPV1 receptors for chronic pain reliefScreening TRPV1 antagonists for the treatment of pain: lessons learned over a decade.Structure-Driven Pharmacology of Transient Receptor Potential Channel Vanilloid 1.Expression and functionality of TRPV1 receptor in human MCF-7 and canine CF.41 cells.Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells.Evolutionary tuning of TRPA1 and TRPV1 thermal and chemical sensitivity in vertebrates.Novel gating and sensitizing mechanism of capsaicin receptor (TRPV1): tonic inhibitory regulation of extracellular sodium through the external protonation sites on TRPV1.Voltage is a partial activator of rat thermosensitive TRP channels.Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1.An alternative splicing product of the murine trpv1 gene dominant negatively modulates the activity of TRPV1 channels.Protein kinase C-mediated Ca2+ entry in HEK 293 cells transiently expressing human TRPV4.The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase.Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.TRPV1 antagonism by capsazepine modulates innate immune response in mice infected with Plasmodium berghei ANKA.Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.Functional characterisation of the S512Y mutant vanilloid human TRPV1 receptor.
P2860
Q24530236-655638F3-1754-4017-BFCD-1E2E61A79FD4Q24672823-C5D0CBC2-B31A-41D4-B8A9-033A5841EA14Q27308057-7D26F775-0881-4451-B900-EF3D17A8E28EQ30434994-80477870-DB8A-4DE0-89E3-647F074BD67CQ31125580-D87C843B-149B-4235-A6D1-92CFBB2598D7Q33688093-A4C0D439-44FC-4E3B-B67A-21BF94A5DA7BQ33934830-FBD6B9C7-78F7-441E-A14E-0FFC64FEDDD9Q35048447-80612DBF-1EBF-4218-A78B-0B6584528297Q35049073-432ACCD6-8BDC-40C6-9F63-FD52AEC3BA75Q35690268-DB694135-ACBB-4052-9EEA-133026715BA6Q35709795-61D218B0-3D35-4B5D-9315-8B0D7FFB4FDBQ36052386-7FADD836-9F6D-4FCE-9A78-68314C570B8FQ36168212-AE5BFC00-8438-4484-A1FB-1CF4B69E9A93Q36179675-C1229A85-E973-4D1C-BAEE-772C4AD6900AQ36315967-3B219129-C164-433A-A1AB-8CA9BCDF6BA9Q36696414-EB1FDE4C-7A50-47D3-BFFC-1847E0D6D4DBQ36977320-2DB4F98A-8A05-4B2B-9244-817F586BC8E6Q37066172-DD09FD08-A87F-4B98-891C-4EC38368CAE8Q37180517-2B1E1DDC-7BDA-44DE-9057-FD5768E38CABQ37245385-5EEF705B-39B3-4F5C-AA1E-AE475725FC7DQ37391727-33C29BC3-AC22-4893-ABE0-94DF4E3F63B8Q37395956-28D5F033-6B3C-4BC5-9D5D-F775651091DBQ37764026-76091C67-39E6-49C9-95A3-6117142BEB4AQ37799398-B127E496-79D6-4390-BCA6-D86918E566C7Q38088356-64DEC804-920B-4991-A9C0-64C5F000A917Q38874068-7B7C118B-CF44-42A0-937C-46ABDD85D512Q39178517-CB7251E5-6B4D-4CD5-A1CC-77B63DBCCA9DQ39195631-EDDD2302-DDBB-4C05-A9C1-EB419E3A2B92Q39348041-120EC248-7C00-4E52-8F33-EBA3BC3FA620Q39416941-10116EDA-88A0-44CC-B3FB-EEB7D124A711Q40019228-5D681847-7461-473E-969B-CA00BAD257D9Q40068777-B7FB4504-FBDB-4B3A-982E-D32FB480608BQ40510014-229C5FCF-180C-44F8-A1B6-57E100996902Q40539024-F7978CD8-0A5A-4E36-9975-2C0670BD1645Q40635328-D1FF04DD-4C65-48BC-BA62-0F3317FCB30EQ40798185-7455BAEA-34A4-4652-93A1-265FAF8F5FA5Q41478711-5591DC1E-FB6A-4466-AC26-87C00896D8D8Q41730961-C9DFB261-3EDE-4B1A-BD77-25C89D3ADDE7Q41921987-341A2B03-BCED-4E2D-B2F0-372744F8D149Q41955641-F1F757C3-7570-4BD1-85F6-ECE7263F7884
P2860
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
description
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im März 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/03/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/03/01)
@nl
наукова стаття, опублікована в березні 2001
@uk
مقالة علمية (نشرت في مارس 2001)
@ar
name
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@ast
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@en
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@nl
type
label
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@ast
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@en
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@nl
prefLabel
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@ast
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@en
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@nl
P2093
P2860
P921
P356
P1476
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)
@en
P2093
A. Chambers
E. Phillips
H. P. Rang
I. F. James
J. Savidge
L. M. McLatchie
P2860
P304
P356
10.1038/SJ.BJP.0703918
P407
P577
2001-03-01T00:00:00Z